Literature DB >> 9933012

Idiopathic giant retinal tears in identical twins.

N A Chaudhry1, H W Flynn, H Tabandeh.   

Abstract

PURPOSE: To report idiopathic unilateral giant retinal tears with retinal detachment in identical twins that occurred 2 weeks apart.
METHODS: Case reports.
RESULTS: In both patients, giant retinal tear and retinal detachment was treated with pars plana vitrectomy, placement of encircling scleral buckle, fluid-perfluorocarbon exchange, endolaser treatment, perfluorocarbon-air exchange, and 16% perfluoropropane injection. One year after retinal detachment surgery, cataract developed in both postoperative eyes. Phacoemulsification with posterior chamber intraocular lens implantation was performed on both eyes. Three and a half years after retinal surgery, corrected visual acuity in both treated eyes was 20/20, and retinal reattachment was successful.
CONCLUSIONS: To our knowledge, this is the first report of idiopathic giant retinal tears in identical twins and raises the issue of genetic influences in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933012     DOI: 10.1016/s0002-9394(98)00299-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  360 degree giant retinal tear as a result of presumed non-accidental injury.

Authors:  S C Lash; C P R Williams; A J Luff; P R Hodgkins
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

2.  Vitrectomy with short term postoperative tamponade using perfluorocarbon liquid for giant retinal tears.

Authors:  M Sirimaharaj; C Balachandran; W C Chan; A P Hunyor; A A Chang; J Gregory-Roberts; A B Hunyor; T J Playfair
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

3.  Rhegmatogenous retinal detachment in Scotland: research design and methodology.

Authors:  Danny Mitry; David G Charteris; David Yorston; Brian W Fleck; Alan Wright; Harry Campbell; Jaswinder Singh
Journal:  BMC Ophthalmol       Date:  2009-03-24       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.